The Global Healthcare Analytics Market was valued at US$ 16758 Mn in the year 2020 and is anticipated to grow at US$ 94339 Mn till 2027 witnessing a CAGR of 28% over the forecast period 2021-2027. Healthcare analytics tools greatly aid in improving financial, clinical and operational performance of healthcare industries. Several innovative technologies are followed by healthcare industries since many days. The advanced analytics has great significance in healthcare systems as they provide insights for managing business effectively. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the healthcare analytics market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of Healthcare Analytics Market. In 2016 March, Advera Health Analytics, a healthcare informatics company, launched Evidex, a web-based platform with structured real-world drug evidence which combines annotated data from curated clinical trial results. In 2012, AAIPharma Services Corp pharmaceutical product development services provider acquired Celsis Analytical Services, a unit of Celsis International Ltd. In 2012, IMS Health (QuintilesIMS) acquired PharmaDeals Ltd., online information provider of licensing, mergers & acquisitions and business transactions about pharmaceutical industry globally.